ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 964

Neutrophil  Extracellular Traps Are Not Only Targets for ACPA-Positive IgG from Rheumatoid Arthritis Patients but Also Directly Trigger Pro- and Anti-Inflammatory Effects Partly Mediated By the C1q Complement Protein

Matthieu Ribon1, Sarra Seninet1, Katarzyna Matyja1, Mireille Sebbag2, Cyril Clavel2, Julie Mussard1, Guy Serre2, Marie-Christophe Boissier3 and Patrice Decker1, 1Inserm UMR 1125, Li2P, University of Paris 13, Sorbonne Paris Cité, Bobigny, France, 2University of Toulouse, UMR 5165 CNRS-1056 Inserm, Toulouse, France, 3Rheumatology Department, Avicenne Hospital, AP-HP, Bobigny, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: ACPA, inflammation and rheumatoid arthritis, Neutrophil Extracellular Traps, pathogenesis, Pathophysiology

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Activated neutrophils (PMN) form neutrophil extracellular traps (NET). Those structures are expelled chromatin fibers composed of DNA and associated proteins. The process, NETosis, is dependent on citrullination, and has been suggested to be pathogenic in rheumatoid arthritis (RA). RA is characterized by the production of anti-citrullinated protein autoantibodies (ACPA) which are specific for the disease. Although RA PMN show enhanced NETosis and RA autoantibodies recognize NET, the potential pathogenic mechanisms triggered by NET are not elucidated. Therefore, we have analyzed the antigenic and inflammatory properties of NET in RA.

Methods: PMN and monocytes were purified from the blood. We have used primary cells freshly isolated from 115 independent healthy donors and RA patients. IgG were purified from healthy donors, from ACPA-positive RA patients and from ACPA-negative patients with rheumatic diseases. Monocytes were differentiated into macrophages by culturing in the presence of M-CSF. Cell purity and IgG binding were estimated by flow cytometry. NETosis was induced in vitro by PMA on adherent PMN and was analyzed by fluorescence microscopy, together with IgG binding. To produce soluble NET, NET were detached from glass by mild nuclease digestion. They were enriched, quantified by fluorescence and spectrophotometry, and characterized by SDS-PAGE and agarose gel. Macrophages/PMN were cultured with soluble NET in the presence/absence of LPS, IgG, NH4Cl or C1q. C1q receptor expression and cell activation were estimated by flow cytometry and by measuring cytokine secretion by ELISA.

Results: Only low binding of IgG was observed by flow cytometry on untreated freshly isolated PMN. Upon NETosis, a strong recognition by ACPA+ IgG was observed, specifically on the NET structures, as demonstrated by fluorescence microscopy. The NET staining with ACPA from RA patients was stronger than with ACPA-negative IgG in 15 out of 19 experiments (79 %; p < 0.05) and normal NET were as antigenic as RA NET. Soluble NET activated both steady-state macrophages and PMN, leading to IL-8 secretion and CD11b up-regulation, independently of ACPA+ IgG. The stimulatory activity of soluble NET on macrophages was increased in the presence of C1q, whereas PMN activation was not influenced by inhibition of endosomal acidification. Soluble NET from both healthy donors and RA patients induced cell activation and have similar immuno-modulatory properties. Likewise, both PMN and macrophages from healthy donors and RA patients responded to soluble NET. On the contrary, soluble NET specifically inhibited LPS-induced IL-6 secretion by macrophages.

Conclusion: ACPA+ IgG from RA patients strongly and specifically recognize NET and not untreated PMN. NET are antigenic and possess both pro- and anti-inflammatory properties depending on the cell type, the activation level and the presence of co-factors like C1q or high expression of its receptors but independently of endolysosomal activity or ACPA. Therefore, an excess of NETosis rather than altered NETosis may be pathogenic in RA and trigger ACPA. This is probably the largest analysis comparing RA/normal NET on RA/normal cells reported so far.


Disclosure: M. Ribon, None; S. Seninet, None; K. Matyja, None; M. Sebbag, None; C. Clavel, None; J. Mussard, None; G. Serre, None; M. C. Boissier, None; P. Decker, None.

To cite this abstract in AMA style:

Ribon M, Seninet S, Matyja K, Sebbag M, Clavel C, Mussard J, Serre G, Boissier MC, Decker P. Neutrophil  Extracellular Traps Are Not Only Targets for ACPA-Positive IgG from Rheumatoid Arthritis Patients but Also Directly Trigger Pro- and Anti-Inflammatory Effects Partly Mediated By the C1q Complement Protein [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/neutrophil-extracellular-traps-are-not-only-targets-for-acpa-positive-igg-from-rheumatoid-arthritis-patients-but-also-directly-trigger-pro-and-anti-inflammatory-effects-partly-mediated-by-the-c/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophil-extracellular-traps-are-not-only-targets-for-acpa-positive-igg-from-rheumatoid-arthritis-patients-but-also-directly-trigger-pro-and-anti-inflammatory-effects-partly-mediated-by-the-c/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology